Patents
Patents for C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
02/2004
02/12/2004US20040028702 Muramic acid derivative compounds
02/05/2004WO2003087118A3 Method for producing beta-l-2'deoxy-thymidine
02/05/2004US20040023900 Derivatives of monosaccharides as cell adhesion inhibitors
02/03/2004US6686483 Reacting an oxidizer with an olefin in presence of ketone
01/2004
01/29/2004WO2003032905A3 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
01/29/2004US20040019191 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases
01/29/2004US20040018995 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; antidiabetic agents
01/28/2004CN1136223C Simple Synthesis of hexa-saccharide sa plant self-defence system activating agent
01/27/2004US6683219 Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
01/15/2004WO2004005308A2 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
01/15/2004WO2004005307A1 Process for the preparation of optically active 3-n-methylamino-1-(2-thienyl)-1-propanol
01/15/2004CA2492446A1 Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
01/13/2004US6677450 N12, n13-bridged sugar derivatives of indolylopyrrolocarbazoles, useful in inhibiting the proliferation of tumor cells
01/08/2004US20040006026 For use as antibiotics, in therapy of infectious diseases
12/2003
12/31/2003WO2002069704A8 Devices and methods for eliminating termite colonies
12/25/2003US20030236397 Process for preparing beta-L-2'deoxy-thymidine
12/24/2003WO2003106395A1 Devices and methods for eliminating termite colonies
12/24/2003WO2003105580A1 Devices and methods for eliminating termite colonies
12/18/2003US20030232766 Combinatorial libraries of monosaccharides
12/11/2003US20030229219 Preparation of phosphorothioate oligomers
12/04/2003WO2003099273A1 Adduct of topiramate and tramadol hydrochloride and uses thereof
12/04/2003CA2486709A1 Adduct of topiramate and tramadol hydrochloride and uses thereof
11/2003
11/27/2003WO2003097656A2 Novel substituted sulfamate anticonvulsant derivatives
11/27/2003CA2485966A1 Novel substituted sulfamate anticonvulsant derivatives
11/26/2003EP1364649A1 Adduct of topiramate and tramadol hydrochioride and uses thereof
11/26/2003EP1363924A1 Avilamycin derivatives
11/25/2003USRE38332 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/25/2003US6653503 Microwave irradiation process for preparing methyl esters
11/18/2003US6649085 Improve the oxidation and bleaching action at low temperatures
11/12/2003EP1360189A1 Formulation of boronic acid compounds
10/2003
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/23/2003WO2003087118A2 Method for producing beta-l-2'deoxy-thymidine
10/09/2003WO2003082846A1 Anomeric derivatives of monosaccharides
10/09/2003CA2480578A1 Anomeric derivatives of monosaccharides
10/08/2003EP1070068B1 Granulatimide derivatives for use in cancer treatment
10/01/2003EP1348712A1 L-nucleic acid derivatives and processes for the synthesis thereof
09/2003
09/24/2003EP1187839B1 Process for large scale preparation of sphingosines and ceramides
09/18/2003US20030176362 For therapy of epilepsy
09/17/2003EP1344109A2 Onium salts and the use therof as latent acids
09/17/2003EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
09/17/2003EP1021426B1 Catalytic asymmetric epoxidation
09/16/2003CA2078519C Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl)methanol
09/04/2003WO2003072587A1 Process for producing nonvolatile thiazolidine compound
09/03/2003EP1192153B1 Method for the enantiomer separation of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo 4.3.0]nonane
09/02/2003US6613896 Method of producing tiazofurin and other C-nucleosides
08/2003
08/21/2003US20030158243 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
07/2003
07/31/2003US20030144543 Microwave irradiation process for preparing methyl esters
07/31/2003US20030144347 Method for treating autoimmune disease
07/29/2003US6600062 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound
07/24/2003US20030139593 Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
07/23/2003EP0811011B1 Carbohydrate conjugated bio-active compounds
07/22/2003US6596857 Preparation of phosphorothioate oligomers
07/16/2003EP1327637A1 Process for the preparation of L-Ribose
07/16/2003EP1326874A2 Topoisomerase inhibitors
07/16/2003EP1326873A1 Combinatorial libraries of monosaccharides
07/09/2003CN1113892C Process for preparation of 2'fluoro-5-methyl-beta-L-arabino-furanosyluridine
07/08/2003US6590085 Derivatives of monosaccharides as cell adhesion inhibitors
07/03/2003US20030124166 Termiticidal bait matrix can be used in a bait station installed in the ground.
07/03/2003US20030124164 Devices and methods for eliminating termite colonies
06/2003
06/19/2003US20030114660 Hybrid oligonucleotide
05/2003
05/27/2003US6569858 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazoles
05/27/2003US6569355 Chiral compounds, and their use as chiral dopants for the preparation of cholesteric liquid-crystalline compositions
05/22/2003WO2003041697A1 Method for treating autoimmune diseases
05/22/2003CA2466519A1 Method for treating autoimmune diseases
05/21/2003EP0835118B1 Utilization of sophorolipids for the preparation of cosmetic products, in particular for the treatment of the skin
05/20/2003US6566523 Reacting mixtures of enantiomers with (-)-2,3:4,6-di-O-isopropylidene-2-keto-L-gulonic acid (or its hydrates) to form salts
05/20/2003US6566510 Morphine-6-glucuronide synthesis
05/14/2003EP1309324A2 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
05/08/2003US20030087230 L-Ribo-LNA analogues
05/02/2003EP1056739B1 Novel cyclic pro-perfumes having modifiable fragrance raw material alcohol release rate
05/01/2003US20030083476 Morphine-6-glucuronide synthesis
05/01/2003US20030082807 Xylo-LNA analogues
04/2003
04/24/2003WO2003032905A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
04/24/2003CA2684419A1 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
04/23/2003CN1106193C Anticonvulsant sulfamate derivs. useful in treating obesity
04/22/2003US6552000 Anticonvulsant derivatives useful in treating autism
04/16/2003CN1105559C Anticonvulsant derivative useful in treating neuropathic pain
04/10/2003US20030069212 Synthesis of A-ring synthon of 19-nor-1alpha, 25-dihydroxyvitamin D3 from (D)-glucose
04/08/2003US6544945 Cyclic pro-perfumes having modifiable fragrance raw material alcohol release rates
04/02/2003EP0998482B1 Process for the preparation of 2'-fluoro-5-methyl-beta-l-arabinofuranosyluridine
03/2003
03/12/2003EP0842942B1 D-pentofuranose derivatives and process for the preparation thereof
03/06/2003WO2002003984A3 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x
01/2003
01/28/2003US6512107 Generating preferential uridine derivative
01/23/2003US20030017187 Termiticidal bait matrix comprising a termiticide selected such that termiticide causes death to 50-100% of termites within 24-84 days after termites begin to ingest termiticide, cellulose, water
01/16/2003WO2003004508A1 Process for production of saccharide oxazoline derivatives
01/08/2003CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/03/2003WO2003000200A2 β-2'-OR 3'-HALONUCLEOSIDES
01/03/2003CA2451745A1 .beta.-2'-or 3'-halonucleosides
12/2002
12/17/2002US6495523 Anticonvulsants; stroke, head trauma, spinal injury, non-fatal cardiac arrest, surgery
12/12/2002WO2002098892A1 Improved synthesis of allofuranose
12/12/2002US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease
12/05/2002WO2002096921A1 Novel glucose derivative inducing apoptosis, process for producing the same, and use thereof as medicine
11/2002
11/21/2002US20020172658 Bait matrices and bait stations for eliminating termite colonies and
11/14/2002WO2002069704A3 Devices and methods for eliminating termite colonies
11/14/2002US20020169114 Formulation of boronic acid compounds
11/05/2002US6476216 Preparation of phosphorothioate oligomers
10/2002
10/22/2002US6469148 Of high isomeric purity, includes reacting a benzaldehyde, zinc chloride solution with galactose, filtering, diluting filtrate with organic solvent, extracting with cold water and ion exchanging to remove zinc ions
10/16/2002EP0932400B1 Anticonvulsant derivatives useful in treating neuropathic pain
10/09/2002EP0827505B1 Selected soluble esters of hydroxyl-containing indolocarbazoles
10/03/2002WO2002030941A3 Topoisomerase inhibitors
1 2 3 4 5 6 7 8 9 10 11 12